Europe PMC
Nothing Special   »   [go: up one dir, main page]

Europe PMC requires Javascript to function effectively.

Either your web browser doesn't support Javascript or it is currently turned off. In the latter case, please turn on Javascript support in your web browser and reload this page.

This website requires cookies, and the limited processing of your personal data in order to function. By using the site you are agreeing to this as outlined in our privacy notice and cookie policy.

ED-B fibronectin as a target for antibody-based cancer treatments.

Author information

Affiliations

  • 1. Department of AntiAngiogenesis Research, Schering AG, Corporate Business Area Oncology, Germany.
      Authors
    • Menrad A 1
    (1 author)

Expert Opinion on Therapeutic Targets, 01 Jun 2005, 9(3):491-500
https://doi.org/10.1517/14728222.9.3.491 PMID: 15948669 

Review

Abstract 

Chemotherapeutic agents for the treatment of solid cancers do not discriminate between malignant and normal tissue, but rather depend on the increased proliferation of tumour cells versus benign cells. To reach therapeutically active concentrations in the tumour, large doses of these rather unspecific compounds have to be given to the patient, often resulting in severe side effects. Therefore, the goal of modern cancer research is the development of highly selective compounds which are able to discriminate between tumour tissue and normal tissue. One promising approach in this direction is antibody-mediated targeted cancer therapy which may either block an important receptor-ligand interaction or deliver a therapeutically active molecule to an otherwise nonfunctional target. A prerequisite for such an approach is the tumour-selective expression of the respective target structure. This review discusses extra domain-B fibronectin as a promising target which is associated with tumour angiogenesis and tumour growth for the development of novel antibody-mediated therapies.

Full text links 

Read article at publisher's site: https://doi.org/10.1517/14728222.9.3.491

References 

Articles referenced by this article (54)

Show 10 more references (10 of 54)

Citations & impact 

Impact metrics

53
Citations
Jump to Citations

Citations of article over time

Alternative metrics

Altmetric item for https://www.altmetric.com/details/35597064
Altmetric
Discover the attention surrounding your research
https://www.altmetric.com/details/35597064

Article citations

Go to all (53) article citations

Similar Articles 

To arrive at the top five similar articles we use a word-weighted algorithm to compare words from the Title and Abstract of each citation.